High materiality8/10
Axsome Therapeutics price target raised to $251 from $242 at Morgan Stanley
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
AXSM target raised to $251; current price $221.21; upside implied.
- Target: $251
- Posted price: $221.21
- Analyst firm: Morgan Stanley
- Analyst: (not specified)
Key facts
- 01
Target: $251
- 02
Posted price: $221.21
- 03
Analyst firm: Morgan Stanley
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.